Patients who switched from established Lipitor therapy to simvastatin experienced a significant 30 percent increase in relative risk of cardiovascular events or death, new observational study shows

"Patients who switched from established Lipitor therapy to simvastatin experienced a significant 30 percent increase in relative risk of cardiovascular events or death, new observational study shows." South African Family Practice, 49(10), pp. i–ii